A survey published in the "British Medical Journal" showed that a fifth of centres were using heat treated commercial Factor 9.

Linked evidence

PRSE0001917 - Letter from A L Bloom C D Forbes & C R Rizza titled HTLV-III Haemophilia and Blood Transfusion published in the British Medical Journal - 22 Jun 1985

Chronology Information

Date:

22 June 1985

Chapter/issue

Blood Products and Addressing Risk: Viral Inactivation